NCT01146990
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
Phase: N/A
Role: Lead Sponsor
Start: Nov 9, 2010
Completion: Aug 13, 2020